Chronic hepaititis B
Clinical trials for Chronic hepaititis B explained in plain language.
Never miss a new study
Get alerted when new Chronic hepaititis B trials appear
Sign up with your email to follow new studies for Chronic hepaititis B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new injection tame chronic hepatitis b?
Disease control Recruiting nowThis early-stage trial is evaluating an investigational drug called ACT201, given as an injection, to see if it is safe and tolerable. The study first tests single and multiple doses in healthy volunteers, then moves to people with chronic hepatitis B whose virus is already suppr…
Matched conditions: CHRONIC HEPAITITIS B
Phase 1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Gene-Silencing shot aims to quiet hepatitis b for good
Disease control Recruiting nowThis early-stage trial tests a new therapy called CRMA-1001, which uses epigenetic gene silencing to turn off the hepatitis B virus in the body. About 66 adults with chronic hepatitis B who are already on antiviral pills will receive one or more IV infusions of the therapy. The m…
Matched conditions: CHRONIC HEPAITITIS B
Phase 1/2 • Sponsor: nChroma Bio • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a shot keep hepatitis b away after 'Cure'? new trial aims to find out
Disease control Recruiting nowThis study tests whether hepatitis B immunoglobulin (HBIG) can help people with chronic hepatitis B stay virus-free after they've cleared the surface antigen (a key sign of cure). Researchers will give HBIG shots to 132 participants who already cleared the virus with standard the…
Matched conditions: CHRONIC HEPAITITIS B
Early phase 1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC